Sino Biopharmaceutical

shooting star over mountain at night

Biotech

F-star breaks free from invoX after $161M acquisition

The antibody-focused biotech is breaking free from invoX Pharma, a U.K.-based subsidiary of Sino Biopharmaceutical.

Gabrielle Masson Apr 4, 2025 10:03am

Photo of three hands placing together three white puzzle pieces

Takeda adds F-Star collab to constellation worth up to $1B

Jul 5, 2023 2:00pm